Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.

Literature DB >> 19796274

Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.

Abstract

Umbilical cord blood has rapidly become a valuable alternative stem cell source for allogeneic haematopoietic stem cell transplantation. Extensive research over the last 20 years has established the safety and efficacy of umbilical cord blood transplantation in both children and adults with a variety of malignant and non-malignant diseases. This research has clearly shown that this stem cell source has several unique characteristics resulting in distinct advantages and disadvantages when compared to transplantation with unrelated bone marrow or peripheral blood stem cells. This article reviews the most recent literature comparing the outcomes after umbilical cord blood transplantation with other alternative stem cell sources.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Year: 2009 PMID： 19796274 PMCID： PMC2782564 DOI： 10.1111/j.1365-2141.2009.07828.x

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

63 in total

1. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation.

Authors: Y Hoshino; H Kimura; N Tanaka; I Tsuge; K Kudo; K Horibe; K Kato; T Matsuyama; A Kikuta; S Kojima; T Morishima
Journal: Br J Haematol Date: 2001-10 Impact factor: 6.998

2. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

Authors: J W van Esser; B van der Holt; E Meijer; H G Niesters; R Trenschel; S F Thijsen; A M van Loon; F Frassoni; A Bacigalupo; U W Schaefer; A D Osterhaus; J W Gratama; B Löwenberg; L F Verdonck; J J Cornelissen
Journal: Blood Date: 2001-08-15 Impact factor: 22.113

3. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.

Authors: F A Al-Kasim; I Thornley; M Rolland; W Lau; R Tsang; M H Freedman; E F Saunders; S Calderwood; J J Doyle
Journal: Br J Haematol Date: 2002-02 Impact factor: 6.998

4. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

Authors: J N Barker; P L Martin; J E Coad; T DeFor; M E Trigg; J Kurtzberg; D J Weisdorf; J Wagner
Journal: Biol Blood Marrow Transplant Date: 2001 Impact factor: 5.742

5. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.

Authors: Franco Locatelli; Vanderson Rocha; William Reed; Françoise Bernaudin; Mehmet Ertem; Stelios Grafakos; Benedicte Brichard; Xiaxin Li; Arnon Nagler; Giovanna Giorgiani; Paul R Haut; Joel A Brochstein; Diane J Nugent; Julie Blatt; Paul Woodard; Joanne Kurtzberg; Charles M Rubin; Roberto Miniero; Patrick Lutz; Thirumalairaj Raja; Irene Roberts; Andrew M Will; Isaac Yaniv; Christiane Vermylen; Nunzia Tannoia; Federico Garnier; Irina Ionescu; Mark C Walters; Bertram H Lubin; Eliane Gluckman
Journal: Blood Date: 2002-11-07 Impact factor: 22.113

Review 6. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.

Authors: L D Cooley; D A Sears; M M Udden; W R Harrison; K R Baker
Journal: Am J Hematol Date: 2000-01 Impact factor: 10.047

7. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission.

Authors: Nancy Bunin; Michael Carston; Donna Wall; Roberta Adams; James Casper; Naynesh Kamani; Roberta King
Journal: Blood Date: 2002-05-01 Impact factor: 22.113

8. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Authors: John E Wagner; Juliet N Barker; Todd E DeFor; K Scott Baker; Bruce R Blazar; Cindy Eide; Anne Goldman; John Kersey; William Krivit; Margaret L MacMillan; Paul J Orchard; Charles Peters; Daniel J Weisdorf; Norma K C Ramsay; Stella M Davies
Journal: Blood Date: 2002-09-01 Impact factor: 22.113

9. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Authors: Navneet S Majhail; Claudio G Brunstein; Marcie Tomblyn; Avis J Thomas; Jeffrey S Miller; Mukta Arora; Dan S Kaufman; Linda J Burns; Arne Slungaard; Philip B McGlave; John E Wagner; Daniel J Weisdorf
Journal: Biol Blood Marrow Transplant Date: 2008-03 Impact factor: 5.742

10. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.

Authors: Stephen P Robinson; Anthony H Goldstone; Stephen Mackinnon; Angelo Carella; Nigel Russell; Carmen Ruiz de Elvira; Goli Taghipour; Norbert Schmitz
Journal: Blood Date: 2002-08-15 Impact factor: 22.113

35 in total

Review 1. Cord blood stem cells for hematopoietic transplantation.

Authors: Anfisa Stanevsky; Avichai Shimoni; Ronit Yerushalmi; Arnon Nagler
Journal: Stem Cell Rev Rep Date: 2011-06 Impact factor: 5.739

2. Cell banks: life blood.

Authors: Melinda Wenner Moyer
Journal: Nature Date: 2013-06-27 Impact factor: 49.962

3. The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation.

Authors: Shinichiro Morishita; Atsuhiro Tsubaki; Kazuki Hotta; Jack B Fu; Shigeo Fuji
Journal: J Int Soc Phys Rehabil Med Date: 2019-05-22

Review 4. Family-directed umbilical cord blood banking.

Authors: Eliane Gluckman; Annalisa Ruggeri; Vanderson Rocha; Etienne Baudoux; Michael Boo; Joanne Kurtzberg; Kathy Welte; Cristina Navarrete; Suzanna M van Walraven
Journal: Haematologica Date: 2011-07-12 Impact factor: 9.941

Review 5. Hematopoetic stem cell transplantation in children.

Authors: Mehmet Akif Yeşilipek
Journal: Turk Pediatri Ars Date: 2014-06-01

Review 6. Umbilical cord blood graft engineering: challenges and opportunities.

Authors: P A Thompson; K Rezvani; C M Hosing; B Oran; A L Olson; U R Popat; A M Alousi; N D Shah; S Parmar; C Bollard; P Hanley; P Kebriaei; L Cooper; J Kellner; I K McNiece; E J Shpall
Journal: Bone Marrow Transplant Date: 2015-06 Impact factor: 5.483